Pre-Post Study for Supporting Appropriate Implementation of Lung Cancer Screening
The primary objective of this study is to assess the effect of the decision aid on measures of decision-making such as knowledge, screening attitudes, decisional conflict, and screening intent.
Checked against the public recordLast updated Sep 20, 2017 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Health Services Research
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Interventions being studied
- Behavioral: Pre/Post Test of a Lung Cancer Screening Decision Aid
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: Subjects must meet all of the following inclusion criteria to participate in this study: * Age 55 - 80; * Current smoker, or former smoker who has less than a 16-year quit history; * Have at least a 30-pack year smoking history (average packs per day \* years smoking); and * Patient of the Internal Medicine Clinic at University of North Carolina Health Care. Exclusion Criteria: All subjects meeting any of the following exclusion criteria at baseline will be excluded from study participation: * Ever diagnosed with lung cancer; * Undergone chemotherapy or radiation therapy in the past 18 months prior to enrollment; * Coughed up blood from lungs (also called hemoptysis) within the past year prior to enrollment; * Experienced unexplained weight loss of 15-pounds or more during six months prior to enrollment; and * Had a chest CT scan within the past 18 months prior to enrollment.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- UNC Ambulatory Care Center Internal Medicine ClinicChapel Hill, North Carolina
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 20, 2017. Always confirm current availability with the study team.